Herbert J. Meiselman
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Herbert J. Meiselman has a total of 7 co-authors. Here are the top co-authors by number of shared publications:
Oguz K. Baskurt
Department of Physiology and Biophysics, University of Southern California School of Medicine, Los Angeles 90033, USA
3 shared publicationsR.B. Wenby
Department of Physiology and Biophysics, University of Southern California, School of Medicine, Los Angeles, CA, USA
2 shared publicationsS.M. Razavian
Department of Physiology and Biophysics, University of Southern California, School of Medicine, Los Angeles 90033, USA
2 shared publicationsT.C. Fisher
Department of Physiology and Biophysics, University of Southern California, School of Medicine, Los Angeles, CA, USA
2 shared publicationsB. Chong‐Martinez
Internal Medicine Department, Especialities Hospital, National Medical Centre, Mexico City, Mexico
1 shared publicationR. B. Wenby
Department of Physiology and Biophysics and
1 shared publication
Latest Publications
- 4 April 2003
- Published by Wiley in Diabetic Medicine
- Vol. 20 (4) , 301-306
Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus
Aims Reports of rheological changes following intensification of metabolic control are limited and not concordant. The present study was designed to test the hypothesis that intensification of management of Type 2 diabetes (T2DM) with diet, exercise and insulin improves haemorheological behaviour by reducing red blood cell (RBC) aggregation.Methods Blood was sampled from 55 subjects before and following 14 ± 3 weeks of intensified management. RBC aggregation was measured in vitro for cells in plasma or in an aggregating 70 kD dextran solution. Plasma viscosity and whole blood viscosity were also measured.Results During treatment, fasting glucose fell 27%, HbA1c fell 21%, and serum triglycerides and total cholesterol fell 28% and 12%, respectively (P < 0.0001 for each). The extent and strength of RBC aggregation in plasma fell by 10–13% (P < 0.002). Similar decreases of RBC aggregation were seen for cells suspended in dextran (P < 0.002). Plasma viscosity decreased by 3% (P < 0.02) and high shear blood viscosity by 6–7% (P < 0.0001). Changes of RBC aggregation in plasma and in dextran were significantly correlated, supporting a cellular rather than a plasmatic origin for these changes. However, there were no significant correlations between RBC aggregation changes and changes of fasting glucose, HbA1c, serum triglycerides, serum cholesterol, or plasma fibrinogen.Conclusions Intensified metabolic control results in a reduction of RBC aggregation that appears to be intrinsic to RBC. Since increased RBC aggregation can impair microcirculatory flow, it is possible that haemorheological factors may contribute to the reduction of microvascular complications resulting from improved metabolic control in T2DM.
- 4 April 2003
- Published by Wiley in Diabetic Medicine
- Vol. 20 (4) , 301-306
Decreased red blood cell aggregation subsequent to improved glycaemic control in Type 2 diabetes mellitus
Aims Reports of rheological changes following intensification of metabolic control are limited and not concordant. The present study was designed to test the hypothesis that intensification of management of Type 2 diabetes (T2DM) with diet, exercise and insulin improves haemorheological behaviour by reducing red blood cell (RBC) aggregation.Methods Blood was sampled from 55 subjects before and following 14 ± 3 weeks of intensified management. RBC aggregation was measured in vitro for cells in plasma or in an aggregating 70 kD dextran solution. Plasma viscosity and whole blood viscosity were also measured.Results During treatment, fasting glucose fell 27%, HbA1c fell 21%, and serum triglycerides and total cholesterol fell 28% and 12%, respectively (P < 0.0001 for each). The extent and strength of RBC aggregation in plasma fell by 10–13% (P < 0.002). Similar decreases of RBC aggregation were seen for cells suspended in dextran (P < 0.002). Plasma viscosity decreased by 3% (P < 0.02) and high shear blood viscosity by 6–7% (P < 0.0001). Changes of RBC aggregation in plasma and in dextran were significantly correlated, supporting a cellular rather than a plasmatic origin for these changes. However, there were no significant correlations between RBC aggregation changes and changes of fasting glucose, HbA1c, serum triglycerides, serum cholesterol, or plasma fibrinogen.Conclusions Intensified metabolic control results in a reduction of RBC aggregation that appears to be intrinsic to RBC. Since increased RBC aggregation can impair microcirculatory flow, it is possible that haemorheological factors may contribute to the reduction of microvascular complications resulting from improved metabolic control in T2DM.
- 1 January 1999
- Vol. 21, 195-200
Hemorheologic alterations in hypertension: chicken or egg?
The serious pathophysiologic consequences of systemic hypertension have prompted numerous basic science and clinical studies related to cardiac or vascular abnormalities. More recently, hemorheologic alterations in hypertension have been explored in an attempt to determine the import of rheologic factors vis-à-vis the elevated total peripheral resistance observed in hypertensive patients. To date, various studies have documented several abnormalities (e.g., increased blood and plasma viscosity, elevated hematocrit), with some suggesting altered RBC or WBC rigidity. However, there is much less information relevant to the "chicken or egg" problems: (1) are reported hemorheological abnormalities the cause or the result of hypertension; (2) does normalization of blood pressure also normalize hemorheological parameters? In overview, the current literature indicates that hemorheology and hypertension may be linked, but that the details of this association and its cause-effect relations remain unclear.
- 1 January 1999
- Vol. 21, 195-200
Hemorheologic alterations in hypertension: chicken or egg?
The serious pathophysiologic consequences of systemic hypertension have prompted numerous basic science and clinical studies related to cardiac or vascular abnormalities. More recently, hemorheologic alterations in hypertension have been explored in an attempt to determine the import of rheologic factors vis-à-vis the elevated total peripheral resistance observed in hypertensive patients. To date, various studies have documented several abnormalities (e.g., increased blood and plasma viscosity, elevated hematocrit), with some suggesting altered RBC or WBC rigidity. However, there is much less information relevant to the "chicken or egg" problems: (1) are reported hemorheological abnormalities the cause or the result of hypertension; (2) does normalization of blood pressure also normalize hemorheological parameters? In overview, the current literature indicates that hemorheology and hypertension may be linked, but that the details of this association and its cause-effect relations remain unclear.
- Open Access
- 1 January 1998
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 63 (1) , 89-93
Activated polymorphonuclear leukocytes affect red blood cell aggregability
Activated leukocytes can affect adjacent cells by generating oxygen free radicals and secreting proteolytic enzymes, and red blood cells (RBC) exposed to such agents should be susceptible to their effects. This study was thus designed to investigate the effects of activated polymorphonuclear leukocytes (PMN) on RBC aggregability (i.e., on intrinsic RBC aggregation characteristics). PMN were isolated from human blood by density separation and suspended in glucose-enriched buffer with RBC isolated from the same blood sample (RBC/PMN ratio of 150:1). PMN were then activated in this suspension by adding 1 ng/mL tumor necrosis factor α (TNF-α) and 10–7 M N-formyl-methionyl-leucyl-phenylalanine (fMLP) or fMLP alone. After incubation for 2 h at 37°, RBC aggregation behavior in autologous plasma was assessed; RBC deformability and partition coefficients were also measured. RBC aggregation was significantly increased after incubation and deformability and partitioning were decreased; these effects were prevented by phenylmethylsulfonyl fluoride (1 mM) or superoxide dismutase (20 μg/mL) plus catalase (40 μg/mL). TNF-α and fMLP alone had no effect on RBC aggregation if PMN were not present. Activated PMN can thus markedly affect RBC aggregability, apparently via both proteolytic enzymes and oxygen free radicals; enhanced aggregation seen in clinical states associated with PMN activation or observed during in vivo RBC aging may also involve such PMN-RBC interactions. J. Leukoc. Biol. 63: 89–93; 1998.
- 1 January 1998
- Published by Oxford University Press (OUP) in Journal of Leukocyte Biology
- Vol. 63 (1) , 89-93
Open AccessActivated polymorphonuclear leukocytes affect red blood cell aggregability
Activated leukocytes can affect adjacent cells by generating oxygen free radicals and secreting proteolytic enzymes, and red blood cells (RBC) exposed to such agents should be susceptible to their effects. This study was thus designed to investigate the effects of activated polymorphonuclear leukocytes (PMN) on RBC aggregability (i.e., on intrinsic RBC aggregation characteristics). PMN were isolated from human blood by density separation and suspended in glucose-enriched buffer with RBC isolated from the same blood sample (RBC/PMN ratio of 150:1). PMN were then activated in this suspension by adding 1 ng/mL tumor necrosis factor α (TNF-α) and 10–7 M N-formyl-methionyl-leucyl-phenylalanine (fMLP) or fMLP alone. After incubation for 2 h at 37°, RBC aggregation behavior in autologous plasma was assessed; RBC deformability and partition coefficients were also measured. RBC aggregation was significantly increased after incubation and deformability and partitioning were decreased; these effects were prevented by phenylmethylsulfonyl fluoride (1 mM) or superoxide dismutase (20 μg/mL) plus catalase (40 μg/mL). TNF-α and fMLP alone had no effect on RBC aggregation if PMN were not present. Activated PMN can thus markedly affect RBC aggregability, apparently via both proteolytic enzymes and oxygen free radicals; enhanced aggregation seen in clinical states associated with PMN activation or observed during in vivo RBC aging may also involve such PMN-RBC interactions. J. Leukoc. Biol. 63: 89–93; 1998.
- 31 October 1997
- Published by Elsevier
- Vol. 34 (4) , 349-362
Determination of particle sedimentation rate by ultrasonic interferometry: Role of particle size, density and volume fraction
- 31 October 1997
- Published by Elsevier
- Vol. 34 (4) , 349-362
Determination of particle sedimentation rate by ultrasonic interferometry: Role of particle size, density and volume fraction
- 1 October 1997
- Published by SAGE Publications in Biorheology
- Vol. 34 (4-5) , 349-362
Determination of Particle Sedimentation Rate by Ultrasonic Interferometry: Role of Particle Size, Density and Volume Fraction
The sedimentation rate (SR) of non-aggregated spherical particles in suspension was determined using an ultrasonic interferometry technique (Echo-Cell); this method is based on A-mode echography and measures the rate of formation of a sediment on a s
- 1 October 1997
- Published by SAGE Publications in Biorheology
- Vol. 34 (4-5) , 349-362
Determination of Particle Sedimentation Rate by Ultrasonic Interferometry: Role of Particle Size, Density and Volume Fraction
The sedimentation rate (SR) of non-aggregated spherical particles in suspension was determined using an ultrasonic interferometry technique (Echo-Cell); this method is based on A-mode echography and measures the rate of formation of a sediment on a s
- 1 August 1997
- Published by SAGE Publications in Biorheology
- Vol. 34 (3) , 235-247
Cellular Determinants of Low-Shear Blood Viscosity
Low-shear viscometry is one of the methods commonly used to estimate the degree of red blood cell (RBC) aggregation in various bloods and RBC suspensions. However, it has been previously shown that alterations in RBC morphology and mechanical behavio
- 1 August 1997
- Published by SAGE Publications in Biorheology
- Vol. 34 (3) , 235-247
Cellular Determinants of Low-Shear Blood Viscosity
Low-shear viscometry is one of the methods commonly used to estimate the degree of red blood cell (RBC) aggregation in various bloods and RBC suspensions. However, it has been previously shown that alterations in RBC morphology and mechanical behavio
- 1 May 1997
- Published by Elsevier in Biorheology
- Vol. 34 (3) , 235-247
Cellular determinants of low-shear blood viscosity
- 1 May 1997
- Published by Elsevier in Biorheology
- Vol. 34 (3) , 235-247
Cellular determinants of low-shear blood viscosity